• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Rigel Pharmaceuticals Inc

+ Add to Watchlist


2.2200 USD 0.0200 0.91%

As of 17:10:00 ET on 12/24/2014.

Snapshot for Rigel Pharmaceuticals Inc (RIGL)

Open: 2.2000 Day's Range: 2.1900 - 2.2700 Volume: 378,245
Previous Close: 2.2000 52wk Range: 1.5600 - 5.0000 1-Yr Rtn: -15.91%

Stock Chart for RIGL

No chart data available.
  • RIGL:US 2.2200
  • 1D
  • 1M
  • 1Y
Interactive RIGL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RIGL

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.9700
Est. EPS (USD) (12/2014) -1.0180
Est. PEG Ratio -
Market Cap (M USD) 194.90
Shares Outstanding (M) 87.79
30 Day Average Volume 637,153
Price/Book (mrq) 1.3272
Price/Sale (ttm) 33.7556
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RIGL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RIGL

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. The Company's research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms.

Raul R RodriguezChief Executive OfficerRyan D MaynardExec VP/CFO
Elliott B GrossbardExec VP/Chief Medical OfficerDonald G PayanExec VP/Pres:Discovery
More Company Profile & Key Executives for RIGL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil